Related Experiment Videos
Biomarkers: the clues to genetic susceptibility
1Duke University, Durham, NC, USA.
Abstract:
There are approximately 500,000 cancer-related deaths annually in the United States. Scientists believe as that many as 80% of those deaths could be prevented due to the fact that most malignancies are a result of external factors rather than inherent biological conditions. With recent advances in molecular biology, a new field that combines highly sensitive and specific techniques for detecting early damage associated with cancer has emerged. By combining knowledge about external factors related to lifestyle and environmental or occupational exposure to chemicals with knowledge of how genetic differences cause variations in human responses to environmental pollutants, scientists are developing a better understanding of questions such as why some smokers get cancer but others do not, why certain groups of people have a higher incidence of cancer after exposure to a toxicant and others do not, and why certain women are more prone to develop breast cancer than others. Scientists using biomarkers of susceptibility will be able to identify risks and prevent adverse health effects through prevention and intervention strategies.
Insights
Most cancer deaths are preventable, linked to external factors, not genetics. New molecular biology techniques identify susceptibility biomarkers for early cancer detection and prevention strategies.
Area of Science:
- Molecular biology
- Cancer research
- Biomarker discovery
Background:
- Approximately 500,000 cancer deaths occur annually in the US.
- An estimated 80% of cancer deaths are preventable, linked to external factors like lifestyle and environmental exposures.
- Genetic differences influence individual responses to environmental pollutants, explaining varied cancer incidence.
Discussion:
- Advances in molecular biology enable sensitive detection of early cancer damage.
- Integrating lifestyle, environmental exposure, and genetic data enhances understanding of cancer etiology.
- Investigating why some individuals develop cancer (e.g., smokers, exposed groups, women with breast cancer) while others do not.
Key Insights:
- Biomarkers of susceptibility can identify individuals at higher risk for cancer.
- Understanding genetic predispositions alongside environmental factors is crucial for personalized risk assessment.
- Early detection of molecular damage is key to cancer prevention.
Outlook:
- Biomarker-guided strategies will enable targeted prevention and intervention.
- Personalized medicine approaches will reduce cancer incidence and mortality.
- Continued research in molecular biology and environmental health will refine cancer risk prediction.